naloxone
FDA Approves New OTC Naloxone Nasal Spray for Emergency Use
The opioid overdose reversal drug is a generic of OTC Narcan.
APRIL 29, 2024

Customized EHR Provides Secure Registration for UMass Mobile Addiction Service Unit
A custom EHR module provides secure remote patient registration for “Road to Care,” the mobile ...
NOVEMBER 3, 2023

California Governor Vetoes Bill Requiring Insurance to Cover Low-Cost Naloxone
A bill that would require California insurers to cover the cost of OTC naloxone was vetoed by the state’s ...
OCTOBER 31, 2023

FDA Approves RiVive OTC Naloxone Treatment
The FDA approved the second nonprescription naloxone product.
AUGUST 1, 2023

‘We Are Saving Lives’: The Long Journey to FDA Approval for OTC Naloxone
Efforts to increase access to naloxone—even for harm reduction programs—were still meeting distribution ...
APRIL 4, 2023

Rural Communities Plagued by Nonfatal Overdoses From Combined Meth, Opioid Use
People living in rural communities were more than 50% more prone to a nonfatal overdose when using both ...
FEBRUARY 28, 2023

Out-of-Pocket Cost of Naloxone May Impede Compliance
An observational study published in JAMA Health Forum found that the out-of-pocket cost of naloxone for uninsured ...
FEBRUARY 27, 2023

FDA: Risks to Patients Exposed to Xylazine in Illicit Drugs
Xylazine is not approved for human use and may result in serious and life-threatening AEs that appear to be similar ...
NOVEMBER 17, 2022

FDA Investigating OTC Availability of Naloxone Products
The FDA wants companies to develop OTC naloxone products to make it easier for people to have access to these ...
NOVEMBER 16, 2022

FDA Guidance on Naloxone Distribution Looks to Improve OUD Treatment Access
The FDA is trying to facilitate better naloxone access for opioid use disorder, especially to undeserved ...
SEPTEMBER 27, 2022

COVID-19 Death Toll: More than Just SARS-CoV-2
More than 100,000 people in the United States died from a drug overdose between April 2020 to April 2021.
NOVEMBER 18, 2021

Telehealth Spurs Naloxone During COVID-19
Against the backdrop of a dual opioid epidemic and COVID-19 pandemic, institutions have been rolling out telehealth ...
AUGUST 23, 2021
